Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

PMVP

PMVP News

Newswire

08:05

PMV Pharmaceuticals Reports Q3 2025 Financial Results, Q1 2027 NDA Submission Planned

08:04

PMV Pharma reports 34% ORR in rezatapopt Phase 2 pivotal study.

12:35

PMV Pharmaceuticals' Cash Burn: Assessing Its Growth Potential

17:22

ORBIMED ADVISORS Sells 1M PMV Pharmaceuticals Shares at $1.52 on Oct 23, 2023.

11:45

PMV Pharma reports 34% ORR in 103 evaluable patients across all cohorts.

View More

About PMVP

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More